References
1. ARIIS, "Pétition d'ARIIS pour les présidentielles 2012" (ARIIS Website, 2012).
http://www.ariis.fr, accessed 4 Apr., 2012.
2. A. Torsoli, "French Drugmakers Say Pricing Policy May Hamper Industry" (Bloomberg Website, 2012). http://mobile.bloomberg.com/, 4 Apr., 2012
3. The Pharma Letter, "Tax system for French drug firms to change" (The Pharma Letter Website, 2012).
http://www.thepharmaletter.com/, accessed 4 Apr., 2012.
4. J. Cuadrado and C. Damiano, "French taxes specific to the pharmaceutical industry: cutting the health expenses or a different
way of taxing the profitability of the pharmaceutical industry in France" in Tax on Transactions multi-jurisdictional guide
(Practical Law Company Website, 2011). http://crossborder.practicallaw.com/, accessed 4 Apr., 2012.
5. Anon, "France loses AAA rating as euro governments downgraded" (BBC News Website, Jan. 12, 2012). http://www.bbc.co.uk/news/business-16552623, accessed 4 Apr., 2012.
6. H. Israël and C. Guionnet-Moalic, "France: How the Reform of the Tax Applicable to Pharmaceutical Product Turnover Will
Affect Entities in this Field" (mondaq Website, 2005).
http://www.mondaq.com/ accessed 4 Apr., 2012.
7. CSIS, Meeting of the Health Industries Strategic Advisory Board (Ministère de l'Économie, des Finances et de l'Industrie
website, 2012).
http://www.economie.gouv.fr, accessed 4 Apr., 2012.
8. Focus Reports, "France: The French Revolution" (Focus Reports Website, 2010).
http://www.pharma.focusreports.net/, accessed 4 Apr., 2012.
|
